๐
Veltassa
patiromer
Hyperkalemia
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Veltassa is indicated for the treatment of hyperkalaemia in adults and adolescents aged 12 to 17 years.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/veltassa